Rani Therapeutics Holdings, Inc. (RANI) › Operating Cash FlowRani Therapeutics Holdings, Inc. (RANI) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2020: -$14.96M2021: -$32.24M2022: -$46.52M2023: -$51.24M2024: -$35.50M2025: -$18.71M-$18.71M2020Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$18.71M+47.3%2024-$35.50M+30.7%2023-$51.24M-10.1%2022-$46.52M-44.3%2021-$32.24M-115.5%2020-$14.96M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share